A controlled ,Prospective Study of the Effects of statins on Progression of diabetic nephropathy

UMIN ID: UMIN000001724

Registered date:22/02/2009

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: diabetic nephropathy
• Date of first enrollment: 2008/04/01
• Target sample size: 120
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

diet therapy group
standard therapies group (pravastatin 10mg)
active treatment group (atorvastatin 10mg)

Outcome(s)

• Primary Outcome: Prospective Study of the Effects of Cholesterol-lowering therapy in Between 3 group ( diet therapy group, standard therapies group (pravastatin 10mg), iactive treatment group(atorvastatin10mg )on Progression of diabetic nephropathy.
• Secondary Outcome: 1)Nephropathic analysis in before and after about chemical administration 2)Analysis of LDL-C in before and after about this chemical administration 3)Comparison in diet therapy,atorvastatin,pravastatin in superscription

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: 80years-old
• Gender: Male and Female
• Exclude criteria: 1 While person take statins, or statins administration is done one within three months 2 160/100mm Hg is more than most recent twice sphygmomanometry value together the one where blood pressure control is poor 3 Drifting for three months is higher than 2% more than most recent HbA1c10% recently the one where glycemic control states are defectiveness or insecurity 4 The one that presents nephrotic syndrome 5 The person who judged that others, a family doctor were inadequate 6 Others, Dr.clinical study liability or Dr.clinical study allotment is this clinical study which they intend for it and judged to be inadequate

Related Information

• Primary Sponsor: Fukuiken-Saiseikai Hospital
• Secondary Sponsor: Kanazawa University School of Medicine Hospital
• Source(s) of Monetary Support: Fukuiken-Saiseikai Hospital,Kanazawa University School of Medicine Hospital